Two PDE-5 inhibitors show good results in diabetics

Whistler, British Columbia, Canada-In separate studies, Canadian researchers have found that two newer phosphodiesterase type-5 inhibitors improve erectile function in diabetic men, a population in which erectile dysfunction can be difficult to treat.

Related Content:

Drug Therapy

Pivotal data for lumasiran in PH1 published in NEJM

Nedosiran explored in primary hyperoxaluria type 3

Enrollment completed in pivotal trial of nedosiran for hyperoxaluria